Human Genetics

, Volume 113, Issue 3, pp 258–267

Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease

  • Denise Harold
  • Timothy Peirce
  • Valentina Moskvina
  • Amanda Myers
  • Susan Jones
  • Paul Hollingworth
  • Pamela Moore
  • Simon Lovestone
  • John Powell
  • Catherine Foy
  • Nicola Archer
  • Sarah Walter
  • Amanda Edmonson
  • Stephen McIlroy
  • David Craig
  • Peter A. Passmore
  • Alison Goate
  • John Hardy
  • Michael O'Donovan
  • Julie Williams
  • Malcolm Liddell
  • Michael J. Owen
  • Lesley Jones
Original Investigation

Abstract

There is substantial evidence for a susceptibility gene for late-onset Alzheimer's disease (AD) on chromosome 10. One of the characteristic features of AD is the degeneration and dysfunction of the cholinergic system. The genes encoding choline acetyltransferase (ChAT) and its vesicular transporter (VAChT), CHAT and SLC18A3 respectively, map to the linked region of chromosome 10 and are therefore both positional and obvious functional candidate genes for late-onset AD. We have screened both genes for sequence variants and investigated each for association with late-onset AD in up to 500 late-onset AD cases and 500 control DNAs collected in the UK. We detected a total of 17 sequence variants. Of these, 14 were in CHAT, comprising three non-synonymous variants (D7N in the S exon, A120T in exon 5 and L243F in exon 8), one synonymous change (H547H), nine single-nucleotide polymorphisms in intronic, untranslated or promoter regions, and a variable number of tandem repeats in intron 7. Three non-coding SNPs were detected in SLC18A3. None demonstrated any reproducible association with late-onset AD in our samples. Levels of linkage disequilibrium were generally low across the CHAT locus but two of the coding variants, D7N and A120T, proved to be in complete linkage disequilibrium.

References

  1. Abraham R, Myers A, Warrant DeVrieze F, Hamshere ML, Thomas HV, Marshall H, Compton D, Spurlock G, Turic D, Hoogendoorn B, Kwon JM, Petersen RC, Tanaglos E, Norton J, Morris JC, Bullock R, Liolitsa D, Lovestone S, Hardy J, Goate A, O'Donovan M, Williams J, Owen MJ, Jones L (2001) Substantial linkage disequilibrium across the insulin degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 109:646–652CrossRefPubMedGoogle Scholar
  2. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290:2302–2303PubMedGoogle Scholar
  3. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995) Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64:749–760PubMedGoogle Scholar
  4. Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496PubMedGoogle Scholar
  5. Chireux MA, Le Van Thai A, Weber MJ (1995) Human choline acetyltransferase gene: localization of alternative first exons. J Neurosci Res 40:427–438PubMedGoogle Scholar
  6. Cooper HM, Hedges LV (1994) The handbook of research synthesis. Russel Sage, New YorkGoogle Scholar
  7. Davies P (1979) Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 171:319–327PubMedGoogle Scholar
  8. Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II:1403Google Scholar
  9. Daw Warwick E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM (2000) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196–204PubMedGoogle Scholar
  10. Erickson JD, Varoqui H, Schafer MK-H, Modi W, Diebler M-F, Weihe E, Rand J, Eiden LE, Bonner TI, UsdinTB (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 269:21929–21932PubMedGoogle Scholar
  11. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290:2303–2304CrossRefPubMedGoogle Scholar
  12. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedGoogle Scholar
  13. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137–147PubMedGoogle Scholar
  14. Hahm SH, Chen L, Patel C, Erickson J, Bonner TI, Weihe E, Schafer MK, Eiden LE (1997) Upstream sequencing and functional characterization of the human cholinergic gene locus. J Mol Neurosci 9:223–236PubMedGoogle Scholar
  15. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154–159Google Scholar
  16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 23:939–944Google Scholar
  17. Mubumbila V, Sutter A, Ptok U, Heun R, Quirin-Stricker C (2002) Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett 333:9–12CrossRefPubMedGoogle Scholar
  18. Myers AJ, Goate AM (2001) The genetics of late-onset Alzheimer's disease. Curr Opin Neurol 14:433–440CrossRefPubMedGoogle Scholar
  19. Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze FW, Crook R, Hamshere M, Abraham R, Tunstall N, Rice F, Carty S, Lillystone S, Kehoe P, Rudrasingham V, Jones L, Lovestone S, Perez-Tur J, Williams J, Owen MJ, Hardy J, Goate AM (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290:2304–2305CrossRefPubMedGoogle Scholar
  20. Nordberg A, Svensson AL (1998) Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Saf 19:465–480PubMedGoogle Scholar
  21. Oda Y, Nakanishi I, Deguchi T (1992) A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Res Mol Brain Res 16:287–294CrossRefPubMedGoogle Scholar
  22. Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG (2001) Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci USA 98:2017–2022CrossRefPubMedGoogle Scholar
  23. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet I:189Google Scholar
  24. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2:1457–1459PubMedGoogle Scholar
  25. Sham PC, Curtis D (1995) Monte-Carlo test for association between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97–105PubMedGoogle Scholar
  26. Terwilliger J, Ott J (1994) Handbook of human genetic linkage. Johns Hopkins University Press, BaltimoreGoogle Scholar
  27. Touissaint JL, Geoffroy V, Schmitt M, Werner A, Garnier JM, Simoni P, Kempf J (1992) Human choline acetyltransferase (CHAT): partial gene sequence and potential control regions. Genomics 12:412–416PubMedGoogle Scholar
  28. Wilcock GK, Esiri MM, Bowen DM, Smith CC (1982) Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 57:407–417PubMedGoogle Scholar
  29. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239PubMedGoogle Scholar
  30. Xie X, Ott J (1993) Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53:1107PubMedGoogle Scholar
  31. Zhao H, Curtis D, Sham PC (2000) Model-free analysis and permutation tests for allelic associations. Hum Hered 50:133–139PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Denise Harold
    • 1
  • Timothy Peirce
    • 1
  • Valentina Moskvina
    • 1
  • Amanda Myers
    • 3
  • Susan Jones
    • 1
  • Paul Hollingworth
    • 1
  • Pamela Moore
    • 1
  • Simon Lovestone
    • 4
  • John Powell
    • 4
  • Catherine Foy
    • 4
  • Nicola Archer
    • 4
  • Sarah Walter
    • 4
  • Amanda Edmonson
    • 4
  • Stephen McIlroy
    • 5
  • David Craig
    • 5
  • Peter A. Passmore
    • 5
  • Alison Goate
    • 6
  • John Hardy
    • 3
  • Michael O'Donovan
    • 1
  • Julie Williams
    • 1
  • Malcolm Liddell
    • 1
  • Michael J. Owen
    • 1
  • Lesley Jones
    • 1
    • 2
  1. 1.Department of Psychological MedicineUniversity of Wales College of MedicineCardiffUK
  2. 2.Institute of Medical GeneticsUniversity of Wales College of MedicineCardiffUK
  3. 3.Laboratory of Neurogenetics, MSC 0900, Building 9, Room 1N108, National Institute of AgingNational Institute of HealthBethesda USA
  4. 4.Institute of PsychiatryLondonUK
  5. 5.Department of Geriatric MedicineQueen's University BelfastBelfastUK
  6. 6.Departments of Psychiatry and NeurologyWashington University School of MedicineSt LouisUSA

Personalised recommendations